Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma 2018-06-22 08:07
TOT BIOPHARM's 16,000L-capacity monoclonal antibodies production base put into operation 2018-06-21 10:40
CStone enrolls first patient in Phase I study for MEK inhibitor CS3006 in Australia 2018-06-20 19:07
China Biologic Announces Receipt of Non-Binding Acquisition Proposal 2018-06-19 20:00
Alpha Biopharma Announces Series A Financing 2018-06-19 17:36
CStone Pharmaceuticals Initiates Two Pivotal Phase II Studies of the Anti-PD-L1 Monoclonal Antibody CS1001 2018-06-13 15:09
Dr. Ming Liu joins ChemPartner as Vice President and Head of Biology and Pharmacology 2018-06-12 23:00
PBTC and Senhwa sign cooperation agreement to develop CX-4945 for pediatric brain tumor treatment 2018-06-12 21:00
Sinovac Biotech Relaunches Company Website 2018-06-11 21:00
China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant 2018-06-11 20:00
Concord Medical Announces Agreement to Sell Equity Interest in Beijing Allcure Medical Information Technology Ltd 2018-06-05 20:00
WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership 2018-05-30 08:34
OliX Pharmaceuticals receives Clinical Trial Authorization in the UK to initiate Phase I study with OLX10010, an anti-scar RNAi therapeutics 2018-05-29 16:01
Commencement of BNC210 Phase 2 Clinical Trial for the Treatment of Agitation 2018-05-24 21:00
Samsung BioLogics Receives an additional FDA Approval for its world largest Plant's Production 2018-05-24 12:05
EmeTerm Anti-Nausea and Vomiting Wristband is FDA Cleared 2018-05-21 21:00
WuXi Biologics and Bioasis Announce Initial Strategic Collaboration for the Development and Manufacturing of Bioasis' Lead Investigational Candidate to Treat Brain Cancer 2018-05-21 20:30
GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines 2018-05-21 07:00
Shineco, Inc. Reports Third Quarter of 2018 Financial Results 2018-05-18 04:30
iSTAR Medical's MINIject delivers exceptional 6-month results in first-in-human trial 2018-05-16 18:51
1 236 237 238 239 240 430